| Title |
Author |
Type |
Date |
Words |
| LAS VEGAS SANDS / ADELSON TAKES LEAVE FOR CANCER TREATMENT. |
|
|
Jan 8, 2021 |
211 |
| AstraZeneca receives EU approval for leukaemia treatment. |
|
|
Nov 10, 2020 |
314 |
| Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications. |
|
|
Oct 7, 2020 |
235 |
| Approval for drugs to fight 4 cancers. |
VIVIENNE AITKEN Health Editor |
|
Sep 8, 2020 |
170 |
| Treatment of childhood Hodgkin lymphoma in sub-Saharan Africa: A report from the French-African Paediatric Oncology Group (GFAOP). |
Traore, F.; Akonde, F.B. Diagne; Togo, B.; Moreira, C.; Rakotomahefa, N.M.; Pondy, A.; Bouda, C.; Ha |
Clinical report |
Sep 1, 2020 |
4834 |
| Nawton schoolgirl Grace highlights plight of cancer research funding due to Covid-19; A Nawton schoolgirl, who is celebrating one year since completing treatment for cancer, is calling on people to help tackle the devastating loss of funding for cancer research. |
|
|
Aug 5, 2020 |
515 |
| MorphoSys And Incyte Celebrate US Green Light For Blood Cancer Drug. |
|
|
Aug 3, 2020 |
151 |
| Roche In US Breakthrough Status For Cancer Drug; Teams With Blueprint. |
|
|
Jul 14, 2020 |
374 |
| Oncternal Therapeutics announces orphan drug designations of cirmtuzumab by FDA. |
|
|
Jun 30, 2020 |
178 |
| FDA approves Takeda's Alunbrig as first-line treatment for rare lung cancer. |
|
|
May 22, 2020 |
191 |
| Delayed Chylothorax during Treatment of Follicular Lymphoma with a Malignant Pleural Effusion. |
Ekeke, Chigozirim N.; Chan, Ernest G.; Luketich, James D.; Dhupar, Rajeev |
|
Mar 31, 2020 |
1556 |
| Probe into treatment of cancer patient. |
|
Disease/Disorder overview |
Mar 14, 2020 |
269 |
| FDA Accepts of New Drug Application for Filing with Priority Review for Tazverik for the Treatment of Follicular Lymphoma. |
|
|
Feb 18, 2020 |
528 |
| Girl, 13, battling with cancer says rescue dog 'saved' her at lowest point; Gracie Pope was 'given strength' by a stray dog rescued by her family when she was diagnosed with stage four Hodgkin's lymphoma and underwent gruelling treatment. |
By, Kelly Jenkins |
|
Jan 11, 2020 |
391 |
| Epizyme submits tazemetostat NDA to FDA for treatment of follicular lymphoma. |
|
|
Dec 19, 2019 |
264 |
| Epizyme submits tazemetostat NDA to FDA for treatment of follicular lymphoma. |
|
|
Dec 19, 2019 |
268 |
| Clinical Spectrum and Treatment Outcomes of HIV Associated Cancers in a Tertiary Care Centre. |
Elumalai, Senthilkumar; Kannan, Kalaichelvi; Sundarrajan, Sureshkumar; Gopal, Raja |
Report |
Dec 16, 2019 |
2551 |
| AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. |
|
|
Nov 25, 2019 |
216 |
| AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. |
|
|
Nov 25, 2019 |
212 |
| Verastem Oncology submits Marketing Authorization Application to European Medicines Agency for COPIKTRA for cancer patients. |
|
|
Nov 25, 2019 |
237 |
| Verastem Oncology submits Marketing Authorization Application to European Medicines Agency for COPIKTRA for cancer patients. |
|
|
Nov 25, 2019 |
233 |
| Calquence Approved to Treat CLL, SLL; Progression free-survival longer with Calquence versus other standard treatments. |
|
|
Nov 22, 2019 |
295 |
| FDA approves Brukinsa therapy to treat patients with relapsed and refractory mantle cell lymphoma. |
|
|
Nov 15, 2019 |
230 |
| FDA approves Brukinsa therapy to treat patients with relapsed and refractory mantle cell lymphoma. |
|
|
Nov 15, 2019 |
226 |
| Viracta receives FDA's FTD for nanatinostat -valganciclovir combination for treating EBV-associated lymphomas. |
|
|
Nov 13, 2019 |
218 |
| Viracta receives FDA's FTD for nanatinostat -valganciclovir combination for treating EBV-associated lymphomas. |
|
|
Nov 13, 2019 |
214 |
| US FDA supplemental New Drug Application submitted for AbbVie's IMBRUVICA in combination with rituximab. |
|
|
Nov 12, 2019 |
221 |
| US FDA supplemental New Drug Application submitted for AbbVie's IMBRUVICA in combination with rituximab. |
|
|
Nov 12, 2019 |
217 |
| Abbvie (NYSE: ABBV) - AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA[R] (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia -- 8/11/2019. |
|
|
Nov 11, 2019 |
359 |
| Sareum Holdings to showcase potential of new cancer drug at leading industry conference. |
|
Conference news |
Sep 28, 2019 |
235 |
| Pfizer UK - FDA Approves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions -- 23/7/2019. |
|
|
Aug 14, 2019 |
373 |
| Pfizer UK - FDA Approves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions - 23/7/2019. |
|
|
Aug 6, 2019 |
372 |
| Pfizer UK - FDAApproves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions -- 23/7/2019. |
|
|
Aug 1, 2019 |
360 |
| FDA Approves Pfizer's Biosimilar, Ruxience (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions. |
|
|
Jul 25, 2019 |
267 |
| Doctors 'made anxiety error' in cancer patient's treatment; medics mistook side effects, inquest hears. |
|
|
Jul 23, 2019 |
642 |
| Treatment of leukemia, lymphoma and other blood cancers among Filipinos now offers real hope for cure. |
|
|
Jun 21, 2019 |
1510 |
| FDA Grants Genentech's Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma. |
|
|
Jun 12, 2019 |
950 |
| Roche Gets Accelerated Approval In US For Lymphoma Drug Polivy. |
|
|
Jun 11, 2019 |
333 |
| FDA grants Genentech's Polivy accelerated approval in aggressive lymphoma. |
|
|
Jun 10, 2019 |
187 |
| FDA Approves Revlimid In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma. |
|
|
May 30, 2019 |
242 |
| Celgene Corporation (NASDAQ: CELG) - FDA Approves REV LI MID[R] (Lenalidomide) In Combination With Rituximab For the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma -- 28/5/2019. |
|
|
May 29, 2019 |
622 |
| Celgene announces FDA approval of Revlimid/rituximab combo. |
|
|
May 28, 2019 |
139 |
| Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech Announces FDA Approval for Venclexta plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia -- 15/5/2019. |
|
|
May 20, 2019 |
538 |
| First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute. |
|
|
Mar 21, 2019 |
631 |
| European Medicines Agency's committee recommends Pfizer's lung cancer drug. |
|
|
Mar 5, 2019 |
188 |
| European Medicines Agency's committee recommends Pfizer's lung cancer drug. |
|
|
Mar 5, 2019 |
184 |
| UAE expat freezes her eggs before cancer treatment. |
|
|
Feb 26, 2019 |
647 |
| Celltrion and Teva Announce FDA Approval of Truxima, a Biosimilar to Rituxan, for Three Non-Hodgkin's Lymphoma Indications. |
|
|
Dec 6, 2018 |
360 |
| Nordic Nanovector selects first US clinical trial site for Betalutin Lymphoma drug. |
|
|
Oct 29, 2018 |
260 |
| Nordic Nanovector selects first US clinical trial site for Betalutin Lymphoma drug. |
|
|
Oct 29, 2018 |
256 |
| Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. |
|
|
Oct 4, 2018 |
205 |
| Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. |
|
|
Oct 4, 2018 |
201 |
| Cancer treatment contributed to death of Lewis, 20. |
|
|
Sep 5, 2018 |
513 |
| Chinese regulator accepts BeiGene's NDA for Hodgkin's lymphoma treatment. |
|
|
Aug 31, 2018 |
243 |
| Chinese regulator accepts BeiGene's NDA for Hodgkin's lymphoma treatment. |
|
|
Aug 31, 2018 |
239 |
| China National Drug Administration grants marketing authorisation to Roche's Alecensa. |
|
|
Aug 22, 2018 |
175 |
| China National Drug Administration grants marketing authorisation to Roche's Alecensa. |
|
|
Aug 22, 2018 |
171 |
| Gaza without Cancer Medicine as Haley Blames Arabs for Washington's Sins. |
|
|
Aug 22, 2018 |
1417 |
| How mum put life-saving cancer treatment on hold so she could have children. |
|
|
Aug 16, 2018 |
922 |
| Mum: I put my treatment for cancer on hold to have children. |
|
|
Aug 16, 2018 |
1002 |
| Celgene Study of Revlimid/Rituximab Combination for Treatment of Relapsed/Refractory Indolent Lymphoma Demonstrates Improvement in PFS. |
|
Clinical report |
Jul 26, 2018 |
228 |
| Baylor University Medical Center and Texas Oncology begin breakthrough CAR-T cancer treatment for patients with non-Hodgkin's lymphoma. |
|
Brief article |
Jul 1, 2018 |
241 |
| US FDA Grants Fast Track Designation to Nordic Nanovector for Betalutin for Follicular Lymphoma. |
|
|
Jun 15, 2018 |
295 |
| Nordic Nanovector's Betalutin granted Fast Track Designation by US FDA for follicular lymphoma. |
|
|
Jun 12, 2018 |
407 |
| Nordic Nanovector's Betalutin granted Fast Track Designation by US FDA for follicular lymphoma. |
|
|
Jun 12, 2018 |
403 |
| AbbVie wins US FDA approval for VENCLEXTA in combination with rituximab for treating chronic lymphocytic leukemia. |
|
|
Jun 11, 2018 |
275 |
| AbbVie wins US FDA approval for VENCLEXTA in combination with rituximab for treating chronic lymphocytic leukemia. |
|
|
Jun 11, 2018 |
271 |
| Pfizer's Xalkori receives FDA breakthrough therapy designation in 2 indications. |
|
|
May 29, 2018 |
152 |
| Sutro Doses First Patients in Clinical Trial of STRO-001 for Treatment of Lymphoma and Multiple Myeloma. |
|
|
Apr 30, 2018 |
302 |
| Save Sebastian; Parents desperate appeal to fund three-year-old's cancer treatment. |
|
|
Apr 28, 2018 |
433 |
| Sutro Doses First Patients in Clinical Trial of STRO-001 for Treatment of Lymphoma and Multiple Myeloma. |
|
|
Apr 27, 2018 |
302 |
| FDA Approves Seattle Genetics' Adcetris in Combination with Chemotherapy for Adults with Certain Hodgkin Lymphomas. |
|
|
Mar 23, 2018 |
349 |
| I still have reduced fertility after cancer treatment so we're just grateful that we have Sam.. 2fm DJ Louise on fears she can't have another baby after battling disease. |
|
|
Mar 16, 2018 |
546 |
| How a son of widow get treatment for lymphoma. |
|
|
Feb 17, 2018 |
259 |
| Young Hodgkin's Lymphoma Rower Grows from Treatment Experience. |
|
|
Feb 2, 2018 |
896 |
| Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment. |
Teow, Sin-Yeang; Yap, Hooi-Yeen; Peh, Suat-Cheng |
|
Jan 1, 2018 |
6723 |
| Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma. |
Mele, Giuseppe; Pastore, Domenico |
|
Jan 1, 2018 |
1671 |
| Seattle Genetics Files sBLA to FDA for Adcetris for Treatment of Hodgkin Lymphoma. |
|
|
Nov 3, 2017 |
310 |
| FDA Approves Genentech's Rituxan Hycela for Subcutaneous Injection in Certain Blood Cancers. |
|
|
Jun 23, 2017 |
730 |
| To ensure availability of Rituximab and Trastuzumab at affordable prices. |
|
|
May 31, 2017 |
542 |
| Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. |
|
|
May 29, 2017 |
278 |
| Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. |
|
|
May 29, 2017 |
274 |
| US FDA Grants Breakthrough Therapy Designation to Pfizer's Lorlatinib Next-Generation ALK/ROS1 Inhibitor for ALK-Positive Metastatic Non-Small Cell Lung Cancer. |
|
|
Apr 27, 2017 |
355 |
| Animal drug approved for canine lymphoma. |
|
|
Apr 1, 2017 |
155 |
| FDA Advisory Committee Unanimously Recommends Approval of Genentech's Subcutaneous Rituximab for Certain Blood Cancers. |
|
|
Mar 30, 2017 |
466 |
| Merck's KEYTRUDA gains European Medicines Agency approval for treatment of Relapsed or Refractory Classical Hodgkin Lymphoma. |
|
|
Mar 27, 2017 |
200 |
| Merck's KEYTRUDA gains European Medicines Agency approval for treatment of Relapsed or Refractory Classical Hodgkin Lymphoma. |
|
|
Mar 27, 2017 |
196 |
| FDA Approves US Merck's Keytruda for Adult and Pediatric Patients with Classical Hodgkin Lymphoma. |
|
|
Mar 15, 2017 |
711 |
| Rituximab maintenance strategy in advanced follicular lymphoma: Facts and controversies. |
Milunovic, Vibor; Patekar, Martina Bogeljic; Jakubac, Karla Misura; Rogulj, Inga Mandac; Radic-Krist |
Report |
Mar 1, 2017 |
9214 |
| Roche gets EU approval for lung cancer drug Alecensa. |
|
|
Feb 22, 2017 |
263 |
| Roche gets EU approval for lung cancer drug Alecensa. |
|
|
Feb 22, 2017 |
259 |
| US FDA Approves Imbruvica for Marginal Zone Lymphoma Patients. |
|
|
Jan 23, 2017 |
314 |
| US FDA Approves Imbruvica as First Treatment for Rare Type of Non-Hodgkin's Lymphoma. |
|
|
Jan 23, 2017 |
543 |
| AbbVie's IMBRUVICA for the treatment of relapsed/refractory (R/R) marginal zone lymphoma wins US FDA approval. |
|
|
Jan 20, 2017 |
296 |
| AbbVie's IMBRUVICA for the treatment of relapsed/refractory (R/R) marginal zone lymphoma wins US FDA approval. |
|
|
Jan 20, 2017 |
292 |
| Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review. |
Mannina, Donato; Loteta, Barbara |
Clinical report |
Jan 1, 2017 |
2283 |
| Novartis Drug Zykadia Beats Chemotherapy In Lung Cancer Patients. |
|
|
Dec 7, 2016 |
400 |
| Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug. |
|
|
Nov 24, 2016 |
206 |
| Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug. |
|
|
Nov 24, 2016 |
202 |
| Patients to miss out on cancer drugs. |
|
|
Aug 10, 2016 |
193 |
| Celgene receives European Commission approval for Revlimid lymphoma treatment. |
|
|
Jul 19, 2016 |
187 |
| Celgene receives European Commission approval for Revlimid lymphoma treatment. |
|
|
Jul 19, 2016 |
183 |
| Anti-cancer compounds target leukemia, lymphoma blood cancers: a new class of drugs drives cancer cells to suicide. |
|
|
Jun 1, 2016 |
521 |
| 'Help us give our Kevin one last chance' FAMILY IN PLEA FOR PS30k TO SEND BUILDER, 26, FOR CONTROVERSIAL CANCER TREATMENT. |
|
|
May 10, 2016 |
302 |
| Genentech, a member of the Roche Group, received approval from the FDA for Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma who did not respond to a Rituxan (rituximab) regimen. |
|
|
May 1, 2016 |
303 |
| ProNAi Therapeutics' oncology drug candidate PNT2258 has been granted Orphan Drug Designation by the FDA for the treatment of diffuse large B-cell lymphoma (DLBCL). |
|
|
May 1, 2016 |
212 |
| Seattle Genetics commences phase one clinical trial of B-cell non-Hodgkin lymphoma treatment. |
|
|
Feb 29, 2016 |
156 |
| AbbVie passes EMA's orphan drug designation for venetoclax for the treatment of acute myeloid leukemia (AML). |
|
|
Feb 29, 2016 |
338 |
| Seattle Genetics commences phase one clinical trial of B-cell non-Hodgkin lymphoma treatment. |
|
|
Feb 29, 2016 |
152 |
| AbbVie passes EMA's orphan drug designation for venetoclax for the treatment of acute myeloid leukemia (AML). |
|
|
Feb 29, 2016 |
334 |
| New class of drug raises hope for blood cancer patients. |
|
|
Feb 18, 2016 |
161 |
| Research Leads to New Treatment for Lymphoma in Dogs and Cats. |
|
|
Jan 13, 2016 |
285 |
| Revolutionary drug that has given cancer victim mum hope. |
|
|
Dec 26, 2015 |
708 |
| Takeda launches new treatment for Hodgkin's lymphoma in Philippines. |
|
|
Oct 17, 2015 |
251 |
| US FDA approves Bristol-Myers Squibb's Opdivo injection for lung cancer. |
|
|
Oct 13, 2015 |
157 |
| US FDA approves Bristol-Myers Squibb's Opdivo injection for lung cancer. |
|
|
Oct 13, 2015 |
153 |
| Promising treatments for lymphoma: antibody therapy, still under evaluation, has been used successfully in people with cancer of the white blood cells. |
|
|
Oct 1, 2015 |
901 |
| Charity's fears as more cancer patients endure treatment wait. |
|
|
Sep 30, 2015 |
144 |
| MRC Technology collaborates with University of Lausanne for lymphoma treatment. |
|
|
Sep 28, 2015 |
127 |
| MRC Technology collaborates with University of Lausanne for lymphoma treatment. |
|
|
Sep 28, 2015 |
123 |
| Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. |
Zhou, Ping; Liu, Peng; Zhou, Sheng-Yu; He, Xiao-Hui; Han, Xiao-Hong; Qin, Yan; Yang, Sheng; Zhang, C |
Report |
Sep 20, 2015 |
4408 |
| CASI Pharmaceuticals unveils anti-cancer drug ZEVALIN in Hong Kong hospitals. |
|
|
Jul 21, 2015 |
224 |
| CASI Pharmaceuticals unveils anti-cancer drug ZEVALIN in Hong Kong hospitals. |
|
|
Jul 21, 2015 |
220 |
| Hodgkin lymphoma treatment recommended. |
|
|
Jul 9, 2015 |
165 |
| Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis. |
Ren, Yuan-Rong; Jin, Yong-Dong; Zhang, Zhi-Hui; Li, Li; Wu, Ping |
Report |
Mar 1, 2015 |
3591 |
| NADIA MUM HOPES TRIAL DRUG WILL EXTEND LIFE; Model tells how new medicine is helping Berenice fight cancer. |
|
|
Dec 29, 2014 |
531 |
| Bone marrow metastasis of prostatic adenocarcinoma with post-treatment foamy-like changes: a diagnostic pitfall. |
Yigit, Nuri; Geyer, Julia Turbiner |
Case study |
Dec 1, 2014 |
1854 |
| Wonder drug killed off my 70 tumours in 2 weeks; PATIENT TELLS OF HIS JOY Ian had weeks to live when armour-piercing cancer treatment put him into remission. |
|
|
Feb 26, 2014 |
454 |
| Companion biomarkers: paving the pathway to personalized treatment for cancer. |
Duffy, Michael J.; Crown, John |
Report |
Oct 1, 2013 |
8274 |
| Cancer monoclonal antibody market to be worth USD 34bn by 2017. |
|
|
Sep 4, 2013 |
175 |
| Celgene Corporation gets US FDA's approval for REVLIMID for treating relapsed or refractory mantle cell lymphoma. |
|
|
Jun 6, 2013 |
251 |
| Research: cancer treatment may increase heart risks: Cleveland Clinic study finds that cancer survivors who had chest radiation therapy may face higher risks after having major heart surgery. |
|
|
Jun 1, 2013 |
482 |
| Leukaemia sufferers' drug hope. |
|
|
May 16, 2013 |
239 |
| Sheffield Varsity scientists pave way for pioneering new cancer treatments. |
|
|
Feb 21, 2013 |
351 |
| E. coli-derived L-asparaginase retains enzymatic and cytotoxic activity in vitro for canine and feline lymphoma after cold storage. |
Wypij, Jackie M.; Pondenis, Holly C. |
Report |
Jan 1, 2013 |
3607 |
| Investigational targeted drug induces responses in aggressive lymphomas. |
|
|
Apr 2, 2012 |
144 |
| Findings to help cancer treatment; University experts in breakthrough. |
|
|
Jan 5, 2012 |
552 |
| Immunomedics unveils novel antibody-based drugs for lymphoma. |
|
|
Dec 13, 2011 |
186 |
| Biovest's BiovaxID gets FDA Orphan Drug status for Waldenstrom's macroglobulinemia. |
|
|
Oct 28, 2011 |
157 |
| Two cases of durable regression of primary B-cell cutaneous lymphoma following mistletoe treatment alone. |
Orange, M.; Lace, A.; Fonseca, M.; Laue, H.B. von; Geider, S. |
Report |
Oct 15, 2011 |
388 |
| Helicobacter pylori infection: a review of current scientific research on the efficacy or potential of herbal medicine for the treatment of H. pylori infection of the gastric mucosa. |
Williams, Lee |
Report |
Sep 22, 2011 |
5465 |
| Seattle Genetics gets FDA ok to treat two types of lymphoma after first medical treatments failed. |
|
|
Sep 1, 2011 |
174 |
| Adcetris gets FDA approval for treatment of two types of lymphoma. |
|
|
Aug 22, 2011 |
283 |
| Does raver's drug have role to play in treating cancer? MODIFIED VERSION OF ECSTASY CAN HELP TO DESTROY DANGEROUS CELLS. |
|
|
Aug 19, 2011 |
579 |
| Targeted drug therapy found highly effective in lung cancer treatment. |
|
|
Jun 4, 2011 |
251 |
| Drug combo therapy to effectively fight against blood cancer on the anvil. |
|
|
Jun 4, 2011 |
201 |
| Drug trial scheme gives hope to cancer patients. |
|
|
May 18, 2011 |
361 |
| Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. |
Gaiolla, Rafael D.; Domingues, Maria A.C.; Niero-Melo, Ligia; de Oliveira, Deilson Elgui |
Disease/Disorder overview |
Apr 1, 2011 |
6101 |
| Genentech and Biogen Idec receives FDA approval for Rituxan for first-line maintenance use in follicular lymphoma. |
|
|
Jan 31, 2011 |
229 |
| Camcer drugs cash; Life-extending treatments approved foruse in region. |
|
|
Jan 28, 2011 |
510 |
| Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. |
Wang, Hui; Ye, Yan; Pan, Si-Yuan; Zhu, Guo-Yuan; Li, Ying-Wei; Fong, David W.F.; Yu, Zhi-Ling |
Report |
Jan 15, 2011 |
5971 |
| New drug shows promise against certain lung cancers. |
|
|
Oct 29, 2010 |
293 |
| 'Smart' lung cancer drug shows promise. |
|
|
Oct 28, 2010 |
513 |
| New oral drug promises treatment for aggressive lymphoma. |
|
Clinical report |
May 27, 2010 |
298 |
| New drug type developed to kill lymphoma cells. |
|
|
May 12, 2010 |
375 |
| Boffins design new class of drug that kills lymphoma cells. |
|
|
Apr 15, 2010 |
417 |
| Novel treatment gives hope to lymphoma, leukemia patients. |
|
|
Feb 27, 2010 |
391 |
| Biovest earns FDA Orphan Drug status for personalised lymphoma vaccine. |
|
|
Jan 8, 2010 |
140 |
| Treatment of nonepitheliotropic cutaneous b-cell lymphoma in an umbrella cockatoo (Cacatua alba). |
Rivera, Samuel; McClearen, James R.; Reavill, Drury R. |
Report |
Dec 1, 2009 |
4587 |
| Targeted immunotherapy may help treat lymphoma. |
|
|
Nov 1, 2009 |
318 |
| Therapy-related hematological disorders following conventional chemotherapy for lymphoid malignancies in children. |
Spasova, Mariya Ivanova; Stoyanova, Angelina Asenova; Moumdjiev, Ivan Nikolov |
Report |
Jul 1, 2009 |
2886 |
| A treatment designed to harness the body's immune system to fight cancer appeared to thwart two forms of the malignancy in studies, boosting prospects for weapons against the disease that act like vaccines. |
|
Brief article |
Jun 8, 2009 |
293 |
| Infections emerge long after cancer's treatment. |
Jancin, Bruce |
|
Jun 1, 2009 |
250 |
| I feel cheated at treatment refusal; FORMER NURSE DENIED DRUGS WHICH COULD HELP BEAT CANCER. |
|
|
Jan 27, 2009 |
662 |
| Hopes lift on cancer drug trial. |
|
|
Aug 16, 2008 |
265 |
| FDA launches safety review of TNF blockers: under investigation are the risks for lymphoma and other cancers from Enbrel, Humira, and Remicade. |
Mechcatie, Elizabeth |
|
Jul 15, 2008 |
846 |
| MGH study finds effective treatment for brain tumor. |
|
Brief article |
Apr 1, 2008 |
114 |
| Billy overjoyed at wonder drug; Cancer treatment ahead of official go-ahead. |
|
|
Mar 1, 2008 |
449 |
| Intensified chemo works for AIDS-related lymphoma; beats CHOP regimen. |
Moon, Mary Ann |
Brief Article |
Oct 1, 2003 |
251 |
| IL-12 may shrink cutaneous T-cell lymphomas in some. (Promising Early Results). |
Mahoney, Diana |
|
Feb 1, 2003 |
409 |
| Immunomedics obtains patent for therapy of B-cell malignancies using antibodies. |
|
Brief Article |
Jun 1, 2001 |
397 |
| Drug aids destruction of lymphoma cells. |
Seppa, N. |
Brief Article |
Dec 9, 2000 |
387 |
